MedLife reported a pro-forma consolidated turnover of RON 1.57 billion, up 20.3% compared to the same period in 2024, and a pro-forma EBITDA of RON 234 million, 21.2% above the level recorded last year.
The growth was mainly supported by the hospital division, which registered a 38% advance, thanks to the recent investments in robotic surgery, the expansion of the range of surgical interventions especially in niche areas.
In addition to the hospital network, the laboratories reported an increase of 18%, while the clinic division reported an increase of 20% due to the constant interest in high-performance imaging services.
Also, Medlife is consolidating its national footprint, in line with the regions already announced, by completing the acquisition of Routine Med in Tulcea and testing the international market by taking over the majority stake in All Clinic in the Republic of Moldova.
In addition to solid financial results, MedLife has accelerated strategic investments in genetics and artificial intelligence, two directions that will fundamentally transform the medicine of the future.
Thus, in the first half of the year, the company invested EUR 3 million in the acquisition of Illumina NovaSeq X Plus, the most advanced sequencing technology in the world, preparing the launch of a large-scale genetic testing program.
Articolul Private healthcare network MedLife reports 20% growth in the first half of 2025 a fost publicat prima dată în Money Buzz! • Știri Economice, Știri Financiare, Știri Business